Results 61 to 70 of about 759,290 (286)
Legibility of prescription medication labelling [PDF]
I continue to appreciate the updated look of the CPJ and the consistent high quality and applicability of the articles. The Original Research contribution1 on the legibility of prescription medication labelling in Canada came at a convenient time for me.
openaire +2 more sources
Sex Hormones Associate With Amyotrophic Lateral Sclerosis Risk and Survival
ABSTRACT Amyotrophic lateral sclerosis (ALS) risk differs by sex and age, implicating sex hormones as potential modifiers. This study examined plasma levels of biologically active sex hormones and their association with ALS odds and survival in cases (females n = 131, males n = 189) and controls (females n = 138, males n = 150) from the University of ...
Stephen A. Goutman +5 more
wiley +1 more source
Mind Your Meds: Safe Opioid Disposal Awareness [PDF]
Driven by the effects of the opioid epidemic on friends, family members, students, and patients, members of the 2019 GEHLI Team “Mission Possible” are dedicated to bolstering educational awareness of safe leftover opioid disposal methods to decrease the ...
at Virginia Commonwealth University, The Grace E. Harris Leadership Institute +7 more
core +1 more source
Objective This study aimed to evaluate the impact of a series of policies that mandated switching patients with inflammatory arthritis (IA) from an originator biologic to a biosimilar in British Columbia, Canada, on health care resource use and cost.
HaoHung Dang +4 more
wiley +1 more source
C19H17FINO4, triclinic, P1̄ (no. 2), a = 7.1158(2) Å, b = 11.1914(3) Å, c = 12.4974(3) Å, α = 73.015(2)°, β = 87.945(2)°, γ = 78.137(2)°, V = 931.19(4) Å3, Z = 2, R gt(F) = 0.0563, wRref (F 2) = 0.1639, T = 293(2) K.
Yuan Jia-Cheng +4 more
doaj +1 more source
Critical-sized calvarial defects remain a formidable clinical challenge due to dyssynchronous immunomodulation-osteogenesis coupling and unregulated growth factor release.
Jiahe Zheng +8 more
doaj +1 more source
This review summarizes artificial intelligence (AI)‐supported nonpharmacological interventions for adults with chronic rheumatic diseases, detailing their components, purpose, and current evidence base. We searched Embase, PubMed, Cochrane, and Scopus databases for studies describing AI‐supported interventions for adults with chronic rheumatic diseases.
Nirali Shah +5 more
wiley +1 more source
C20H20INO5, monoclinic, P21/c (no. 14), a = 14.49960(10) Å, b = 18.5114(2) Å, c = 7.09190(10) Å, β = 95.2400(10)°, V = 1895.57(4) Å3, Z = 4, Rgt(F) = 0.0348, wRref(F2) = 0.0913, T = 293(2) K.
Yuan Jia-Cheng +4 more
doaj +1 more source
Costs and Benefits of Elderly Prescription Drug Coverage: Evidence from Veterans’ Health Care [PDF]
This study tests the impact of a public prescription benefit on Medicare-eligible veterans, utilizing a mid-1990s benefit change in the VA health care system.
Melissa Boyle
core

